These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7523718)

  • 21. Preoperative prediction of pathological tumor volume and stage in clinically localized prostate cancer: comparison of digital rectal examination, transrectal ultrasonography and magnetic resonance imaging.
    McSherry SA; Levy F; Schiebler ML; Keefe B; Dent GA; Mohler JL
    J Urol; 1991 Jul; 146(1):85-9. PubMed ID: 1711590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should prostate cancer status be determined in patients undergoing radical cystoprostatectomy?
    Sanli O; Acar O; Celtik M; Oktar T; Kilicaraslan I; Ozcan F; Tunc M; Esen T
    Urol Int; 2006; 77(4):307-10. PubMed ID: 17135779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.
    Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
    J Urol; 2017 Feb; 197(2S):S200-S207. PubMed ID: 28012755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidental prostate cancer in Asian men: high prevalence of incidental prostatic adenocarcinoma in Chinese patients undergoing radical cystoprostatectomy for treatment of bladder cancer and selection of candidates for prostate-sparing cystectomy.
    Yang X; Monn MF; Liu L; Liu Y; Su J; Lyu T; Gong Y; Wang L; Davidson DD; Cheng L
    Prostate; 2015 Jun; 75(8):845-54. PubMed ID: 25704311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel staging tool for localized prostate cancer: a pilot study using genetic adaptive neural networks.
    Tewari A; Narayan P
    J Urol; 1998 Aug; 160(2):430-6. PubMed ID: 9679892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of percent positive biopsies and endorectal coil MRI in predicting prognosis in intermediate-risk prostate cancer patients.
    D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Schnall M; Tomaszewski JE; Wein A
    Cancer J Sci Am; 1996; 2(6):343-50. PubMed ID: 9166555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer.
    Thomas C; Wiesner C; Melchior S; Gillitzer R; Schmidt F; Thüroff JW
    J Urol; 2008 Nov; 180(5):1938-41; discussion 1941. PubMed ID: 18801501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant?
    Mazzucchelli R; Barbisan F; Scarpelli M; Lopez-Beltran A; van der Kwast TH; Cheng L; Montironi R
    Am J Clin Pathol; 2009 Feb; 131(2):279-83. PubMed ID: 19141388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
    Partin AW; Kattan MW; Subong EN; Walsh PC; Wojno KJ; Oesterling JE; Scardino PT; Pearson JD
    JAMA; 1997 May; 277(18):1445-51. PubMed ID: 9145716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
    Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
    J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the SEARCH database.
    Freedland SJ; Aronson W; Presti JC; Kane CJ; Terris MK; Elashoff D; Amling CL;
    J Urol; 2003 Jun; 169(6):2142-6. PubMed ID: 12771736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staging of prostate cancer. Value of ultrasonography.
    Scardino PT; Shinohara K; Wheeler TM; Carter SS
    Urol Clin North Am; 1989 Nov; 16(4):713-34. PubMed ID: 2683301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens.
    Peller PA; Young DC; Marmaduke DP; Marsh WL; Badalament RA
    Cancer; 1995 Jan; 75(2):530-8. PubMed ID: 7529129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomy.
    Wolters T; Montironi R; Mazzucchelli R; Scarpelli M; Roobol MJ; van den Bergh RC; van Leeuwen PJ; Hoedemaeker RF; van Leenders GJ; Schröder FH; van der Kwast TH
    Prostate; 2012 Jan; 72(1):108-15. PubMed ID: 21538424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transrectal ultrasound and core biopsies for the diagnosis of prostate cancer. A study of pretreatment investigation strategy for patients with suspected prostate cancer.
    Norberg M
    Acta Radiol Suppl; 1994; 393():1-21. PubMed ID: 8184698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.
    Obek C; Louis P; Civantos F; Soloway MS
    J Urol; 1999 Feb; 161(2):494-8; discussion 498-9. PubMed ID: 9915434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of prostate cancer pathologic features in Chinese populations.
    Chuang AY; Chang SJ; Horng CF; Tsou MH
    Urology; 2007 May; 69(5):915-20. PubMed ID: 17482934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impalpable invisible stage T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens--a different view.
    Elgamal AA; Van Poppel HP; Van de Voorde WM; Van Dorpe JA; Oyen RH; Baert LV
    J Urol; 1997 Jan; 157(1):244-50. PubMed ID: 8976263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staging accuracy of magnetic resonance imaging versus transrectal ultrasound in stages A and B prostatic cancer.
    Vapnek JM; Hricak H; Shinohara K; Popovich M; Carroll P
    Urol Int; 1994; 53(4):191-5. PubMed ID: 7855937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.